Rosita Saraceno

Summary

Country: Italy

Publications

  1. ncbi An Italian study on psoriasis and depression
    Maria Esposito
    Department of Dermatology, Tor Vergata University of Rome, Policlinico Tor Vergata, Viale Oxford 81, IT-00133 Rome, Italy
    Dermatology 212:123-7. 2006
  2. ncbi Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis
    Rosita Saraceno
    Department of Dermatology, University of Rome Tor Vergata PTV, Viale Oxford 81, 00133 Rome, Italy
    Pharmacol Res 57:290-5. 2008
  3. ncbi An occlusive dressing containing betamethasone valerate 0.1% for the treatment of prurigo nodularis
    Rosita Saraceno
    Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
    J Dermatolog Treat 21:363-6. 2010
  4. ncbi TNF-α antagonists and nail psoriasis: an open, 24-week, prospective cohort study in adult patients with psoriasis
    Rosita Saraceno
    University of Rome Tor Vergata, Department of Dermatology, Policlinico Tor Vergata, Viale Oxford 81, 00133, Rome, Italy
    Expert Opin Biol Ther 13:469-73. 2013
  5. ncbi Prevalence and management of panic attacks during infliximab infusion in psoriatic patients
    R Saraceno
    Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
    Dermatology 225:236-41. 2012
  6. ncbi Does metabolic syndrome influence psoriasis?
    R Saraceno
    Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
    Eur Rev Med Pharmacol Sci 12:339-41. 2008
  7. ncbi Hydroxyurea associated with concomitant occurrence of diffuse longitudinal melanonychia and multiple squamous cell carcinomas in an elderly subject
    Rosita Saraceno
    Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
    Clin Ther 30:1324-9. 2008
  8. ncbi Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study
    Rosita Saraceno
    Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
    Dermatol Ther 22:391-4. 2009
  9. ncbi Calcipotriene/betamethasone in the treatment of psoriasis: a review article
    Rosita Saraceno
    Policlinico Tor Vergata University of Rome Tor Vergata, Department of Dermatology, Viale Oxford 81, 00133 Rome, Italy
    Expert Opin Pharmacother 10:2357-65. 2009
  10. ncbi Regional distribution of psoriasis in Italy
    R Saraceno
    Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
    J Eur Acad Dermatol Venereol 22:324-9. 2008

Collaborators

Detail Information

Publications33

  1. ncbi An Italian study on psoriasis and depression
    Maria Esposito
    Department of Dermatology, Tor Vergata University of Rome, Policlinico Tor Vergata, Viale Oxford 81, IT-00133 Rome, Italy
    Dermatology 212:123-7. 2006
    ..It is important to consider this association in the overall management of psoriasis...
  2. ncbi Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis
    Rosita Saraceno
    Department of Dermatology, University of Rome Tor Vergata PTV, Viale Oxford 81, 00133 Rome, Italy
    Pharmacol Res 57:290-5. 2008
    ..BMI and body weight did not interfere with the drugs' efficacy. We report a significant weight-gain associated with three different anti-TNF-alpha therapies in a large number of patients affected with psoriasis...
  3. ncbi An occlusive dressing containing betamethasone valerate 0.1% for the treatment of prurigo nodularis
    Rosita Saraceno
    Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
    J Dermatolog Treat 21:363-6. 2010
    ..Prurigo nodularis is a distressing condition characterized by the presence of multiple nodules associated with intense pruritus...
  4. ncbi TNF-α antagonists and nail psoriasis: an open, 24-week, prospective cohort study in adult patients with psoriasis
    Rosita Saraceno
    University of Rome Tor Vergata, Department of Dermatology, Policlinico Tor Vergata, Viale Oxford 81, 00133, Rome, Italy
    Expert Opin Biol Ther 13:469-73. 2013
    ..Treatment of nail psoriasis can be challenging and unsatisfactory. The aim of this study was to compare the efficacy of three different anti-TNF-α agents on nail psoriasis in patients affected by psoriasis...
  5. ncbi Prevalence and management of panic attacks during infliximab infusion in psoriatic patients
    R Saraceno
    Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
    Dermatology 225:236-41. 2012
    ..Psoriasis is a chronic, inflammatory skin disease associated with anxiety and depression. Infliximab (IFX) is a human/mouse chimeric anti-TNF-α antibody effective in the treatment of psoriasis...
  6. ncbi Does metabolic syndrome influence psoriasis?
    R Saraceno
    Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
    Eur Rev Med Pharmacol Sci 12:339-41. 2008
    ..Moreover we suggest that diet counselling and regular nutritional visits should be recommended in some patients to obtain dual benefits...
  7. ncbi Hydroxyurea associated with concomitant occurrence of diffuse longitudinal melanonychia and multiple squamous cell carcinomas in an elderly subject
    Rosita Saraceno
    Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
    Clin Ther 30:1324-9. 2008
    ..Hydroxyurea is a cytostatic agent used to treat myeloproliferative disorders and long-term treatment is associated with mucocutaneous adverse events and nail hyperpigmentation...
  8. ncbi Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study
    Rosita Saraceno
    Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
    Dermatol Ther 22:391-4. 2009
    ..MEL 308 nm, alone and/or combined with khellin 4% offered encouraging results and it may be considered a valid therapeutic option worthy of consideration in the treatment of vitiligo...
  9. ncbi Calcipotriene/betamethasone in the treatment of psoriasis: a review article
    Rosita Saraceno
    Policlinico Tor Vergata University of Rome Tor Vergata, Department of Dermatology, Viale Oxford 81, 00133 Rome, Italy
    Expert Opin Pharmacother 10:2357-65. 2009
    ..In this article, we highlight the advantages of the association of calcipotriene and betamethasone in the treatment of localized plaque-type, scalp and nail psoriasis...
  10. ncbi Regional distribution of psoriasis in Italy
    R Saraceno
    Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
    J Eur Acad Dermatol Venereol 22:324-9. 2008
    ..Psoriasis is a chronic disease affecting skin and joints; the prevalence varies considerably within ethnic groups and countries...
  11. ncbi Methyl aminolaevulinate photodynamic therapy for the treatment of hidradenitis suppurativa and pilonidal cysts
    Rosita Saraceno
    Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
    Photodermatol Photoimmunol Photomed 25:164-5. 2009
    ..MAL-PDT was effective and well tolerated in our patient. The costs of this therapy represent an important limitation, taking into account the high number of sessions that were performed compared with non-melanoma skin cancers...
  12. ncbi Monochromatic excimer light (308 nm) in the treatment of prurigo nodularis
    Rosita Saraceno
    Department of Dermatology, Policlinico Tor Vergata, University of Rome Tor Vergata, Rome, Italy
    Photodermatol Photoimmunol Photomed 24:43-5. 2008
    ..Patients were treated weekly and an average of eight sessions of MEL was given. Follow-up was 4 months. Partial or complete clinical and histological remission was observed in all patients who completed the study (81%)...
  13. ncbi A biological approach in a patient with psoriasis and bullous pemphigoid associated with losartan therapy
    R Saraceno
    Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
    Clin Exp Dermatol 33:154-5. 2008
    ..Coexistence of psoriasis vulgaris with bullous diseases represents also a difficult therapeutic challenge. This rare case of psoriasis and generalized BP triggered by a sartan drug was treated with rituximab and etanercept...
  14. ncbi Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial
    Rosita Saraceno
    Department of Dermatology, University of Rome Tor Vergata, Viale Oxford 81, Rome, Italy
    J Dermatolog Treat 18:361-5. 2007
    ....
  15. ncbi Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment
    Laura D I Renzo
    Division of Human Nutrition, Department of Neuroscience, University of Rome Tor Vergata, Italy
    Dermatol Ther 24:446-51. 2011
    ..The anti-TNF-α therapies could play a key role in the cross talk between adipose tissue and skeletal muscle, mediated by the reduction of TNF-α and interleukin-6 production...
  16. ncbi -174G/C IL-6 gene promoter polymorphism predicts therapeutic response to TNF-α blockers
    Laura Di Renzo
    Department of Neuroscience, Division of Human Nutrition, University of Rome Tor Vergata, Italy
    Pharmacogenet Genomics 22:134-42. 2012
    ..Although TNF-α blockade is a very effective therapy for psoriasis, not all patients achieve a favorable outcome. The association between IL-6 and psoriasis has been investigated but no papers have focused on the pharmacogenetics of IL-6...
  17. ncbi Vitiligo treatment with monochromatic excimer light and tacrolimus: results of an open randomized controlled study
    Steven Nistico
    Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
    Photomed Laser Surg 30:26-30. 2012
    ..However, a complete and long-lasting repigmention of vitiligo patches is difficult to achieve. Combined treatments with novel sources of phototherapy and topical agents represent possible new strategies...
  18. ncbi Different applications of monochromatic excimer light in skin diseases
    Steven Paul Nisticò
    Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
    Photomed Laser Surg 27:647-54. 2009
    ..Ultraviolet radiation has been used for curative purposes in dermatologic conditions, especially in the last 30 years...
  19. ncbi Complete resolution of erythrodermic psoriasis in an HIV and HCV patient unresponsive to antipsoriatic treatments after highly active antiretroviral therapy (Ritonavir, Atazanavir, Emtricitabine, Tenofovir)
    Andrea Chiricozzi
    Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
    Dermatology 225:333-7. 2012
    ..The management of this condition is challenging because immunomodulating and immunosuppressant agents may have variable and partial efficacy, and therefore, antiretroviral treatment represents a potential adjunctive therapeutic option...
  20. ncbi Erysipeloid cutaneous metastasis from bladder carcinoma
    Arianna Zangrilli
    Department of Dermatology, University of Rome Tor Vergata, Viale Oxford 81, 00133, Rome, Italy
    Eur J Dermatol 17:534-6. 2007
    ..We report this case for the unusual clinical features and because an early recognition of cutaneous metastases from genitourinary malignancies is important in clinical practice...
  21. ncbi Treatment of folliculitis with monochromatic excimer light (308 nm)
    Steven P Nisticò
    Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
    Dermatology 218:33-6. 2009
    ..The aim of the study was to prove the efficacy of 308-nm monochromatic excimer light in the treatment of recalcitrant and antibiotic-resistant folliculitis...
  22. ncbi How to manage infections in the era of biologics?
    Rosita Saraceno
    Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
    Dermatol Ther 21:180-6. 2008
    ..A prompt and appropriate management of infections with the emergence of biologics is essential in clinical practice...
  23. ncbi Recent patents and new strategies in the treatment of psoriasis
    Rosita Saraceno
    Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
    Recent Patents Anti-Infect Drug Disc 1:353-64. 2006
    ....
  24. ncbi Profile of certolizumab and its potential in the treatment of psoriatic arthritis
    Maria Sole Chimenti
    Unit of Rheumatology, Allergology, and Clinical Immunology, University of Rome Tor Vergata, Rome, Italy
    Drug Des Devel Ther 7:339-48. 2013
    ..This drug can be considered as a valid treatment in patients affected by PsA. The efficacy and tolerability profiles suggest CZP as a suitable antipsoriatic drug in the treatment of PsA...
  25. ncbi Efficacy of monochromatic excimer light (308 nm) in the treatment of atopic dermatitis in adults and children
    Steven Paul Nisticò
    Department of Dermatology, Policlinico Tor Vergata, Rome, Italy
    Photomed Laser Surg 26:14-8. 2008
    ..To demonstrate the efficacy of light produced by a 308 nm xenon-chloride monochromatic excimer light (MEL) in the treatment of localized lesions of atopic dermatitis (AD) in adults and in children...
  26. ncbi "Bathing trunk" eruption of papules and nodules in a young woman. Eruptive disseminated Spitz naevi
    Andrea Saggini
    Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
    Acta Derm Venereol 91:738-9. 2011
  27. ncbi Infliximab in the treatment of plaque type psoriasis
    Rosita Saraceno
    Department of Dermatology, University of Rome Tor Vergata, Rome, Viale Oxford 81, Rome, Italy
    Clin Cosmet Investig Dermatol 2:27-37. 2009
    ..The efficacy, tolerability and safety profiles suggest infliximab as a suitable anti-psoriatic drug in the long-term treatment of a chronic disease such as plaque-type psoriasis...
  28. ncbi Emerging applications of nanomedicine in dermatology
    Rosita Saraceno
    Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
    Skin Res Technol 19:e13-9. 2013
    ..AIMS: To review therapeutic applications and benefits of nanomedicine in esthetic dermatology, treatment of malignancies, and inflammatory skin diseases...
  29. ncbi Recent patents on melanoma with focus on genetic strategies
    Talia Gramiccia
    Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
    Recent Pat Antiinfect Drug Discov 3:136-44. 2008
    ..The focus of this review is to summarize the emerging patents in the treatment and diagnosis of melanoma related to the latest genetic models and bio-molecular discoveries...
  30. ncbi A 308-nm monochromatic excimer light in the treatment of palmoplantar psoriasis
    S P Nisticò
    Department of Dermatology, University of Rome, Tor Vergata, Italy
    J Eur Acad Dermatol Venereol 20:523-6. 2006
    ..Various reports have shown the efficacy of narrow-band UVB (311-313 nm) and excimer laser (308 nm) in the treatment of psoriasis...
  31. ncbi Influence and variation of the body mass index in patients treated with etanercept for plaque-type psoriasis
    M Esposito
    Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
    Int J Immunopathol Pharmacol 22:219-25. 2009
    ..Patient BMI does not influence psoriasis efficacy parameters. Although the role of anti TNF-alpha molecules on weight regulation need to be confirmed, our study shows that etanercept treatment may induce weight gain and a BMI increase...
  32. ncbi Trimethoprim-sulfamethoxazole induced erythrodermic psoriasis
    Maria Esposito
    J Infect 57:90-2. 2008
  33. ncbi A European perspective on the challenges of managing psoriasis
    Rosita Saraceno
    Dermatology Centre, The University of Manchester, Hope Hospital, Manchester, United Kingdom
    J Am Acad Dermatol 54:S81-4. 2006